Nørgaard, Jakob Nordberg http://orcid.org/0000-0002-8762-0530
Moore, Kari Lenita Falck
Slørdahl, Tobias S. http://orcid.org/0000-0001-7488-4863
Vik, Anders
Tvedt, Tor Henrik Anderson
Schjesvold, Fredrik http://orcid.org/0000-0003-1096-0569
Article History
Received: 4 January 2024
Revised: 27 March 2024
Accepted: 28 March 2024
First Online: 9 April 2024
Competing interests
: Jakob Nordberg Nørgaard: Has received honoraria from Janssen. Kari Lenita Moore: Declares no financial interests. Tobias S. Slørdahl: Honoraria from Takeda, Celgene, Janssen-Cilag, Amgen and Abbvie. Consultancy/advisory board for Bristol Myers Squibb, Celgene, Amgen, Janssen and GSK. Anders Vik: Declares no financial interests. Tor Henrik Anderson Tvedt: Has received honoraria from Janssen and Sanofi. Fredrik Schjesvold: Honoraria: Amgen, BMS, Takeda, Abbvie, Janssen, Novartis, SkyliteDX, Oncopeptides, Sanofi, Schain, Pfizer, Daiki-Sankyo; Consultancy: GSK, Celgene, Takeda, Janssen, Oncopeptides, Sanofi.